←Back to list

ALZHEON

Biotechnology company with a recent SEC Form D offering.
Biotechnology company headquartered in FRAMINGHAM, MASSACHUSETTS. Filed SEC Form D on 20260910 for a $78.8M Regulation D offering.
Biotech 📍 FRAMINGHAM, MASSACHUSETTS
Current Valuation
Private
PRIVATE

IPO Outlookprivate

Is ALZHEON going public?
No. ALZHEON is private and has not filed to go public. There is no S-1 on file.
What is ALZHEON's valuation in 2026?
No confirmed valuation is on record for ALZHEON. The roster shows funding and investors where they are public; it does not estimate a mark.
Has ALZHEON filed an S-1?
No public S-1 is on file for ALZHEON.
How much has ALZHEON raised?
ALZHEON has raised $78.8M in total, most recently a Form D filing of $78.8M in 20260910.
Is ALZHEON publicly traded — can you buy ALZHEON stock?
No. ALZHEON is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for ALZHEON on its Pre-IPO Access Desk.
How to actually get exposure to ALZHEON →
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.

Company Profile

HQ
FRAMINGHAM, MASSACHUSETTS
Total Raised
$78.8M
Growth
Filed SEC Form D on 20260910 for $78.8M Regulation D offering
Last Round
Form D filing — $78.8M (20260910)
IPO Status
private

Fundraising Status

Form D filing · $78.8M
privateTotal raised $78.8M

Latest Funding Round

RoundAmountDateLead InvestorPost-Money
Form D filing$78.8M20260910——

Vertical Intelligence — Biotech / Gene Therapy

Registered trials
6
1 active · 1 recruiting
Lead phase
Phase 3
most advanced registered study
Focus areas
Early Alzheimer's Disease
Alzheimer Disease · Healthy Participants Study
Latest trial start
2026-03-09
Name-verified against lead sponsor "Alzheon Inc." on ClinicalTrials.gov as of 2026-10-22. Verify on ClinicalTrials.gov ↗

Talent Signal

No public careers page or job board could be found for ALZHEON as of 2026-10-14. That itself is a datapoint: no open external hiring surface.
Checked the company site and major hosted job boards. Re-checked monthly.
BiotechForm DRecently Funded
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.